Overview +

Squamous Cell Carcinoma PBMC

Squamous Cell Carcinoma PBMC is collected from IRB-consented donors diagnosed with clinically confirmed Squamous Cell Carcinoma (SCC). These peripheral blood mononuclear cell (PBMC) samples are ideal for analyzing peripheral immune exhaustion and tumor-specific cell subsets. PBMCs are ideal for evaluating immune checkpoint expression, T cell dysfunction, and cellular response to squamous epithelial tumors.

Product Features

  • Cryopreserved, clinically verified SCC PBMC samples
  • Cryopreserved to ensure stability and long-term storage
  • Research Use Only (RUO)

Donor Metadata

  • Clinically confirmed SCC diagnosis
  • Donor demographics: age, sex assigned at birth, ethnicity
  • Medical and treatment history available when applicable

Applications

  • Analyzing peripheral immune exhaustion and tumor-specific cell subsets
  • Biomarker discovery and validation
  • Transcriptomic, proteomic, or functional studies
  • Custom assay development and disease modeling

Compliance and Quality

  • IRB-approved collection and electronic informed consent
  • HIPAA-compliant donor data handling

Ordering and Customization

Squamous Cell Carcinoma PBMC is available in standard and custom volumes. Contact [email protected] for international requests or documentation needs.

Protocols and Documentation +

Document Type Technical Document
PDF > PBMC Isolation from Whole Blood
PDF > Immune Cell Isolation
PDF > Choosing the Right PBMC Configuration
PDF > Thawing Cryopreserved PBMC

Publications +

Data and Testing +

Data and Testing with Every Sample

  • Donor demographics
  • Donor-reported allergies
  • Donor-reported infectious disease history

Compliance & Quality Assured

For quality and compliance related information, please visit Sanguine quality and compliance page.

For privacy related information, please visit Sanguine privacy policy page.